Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: Implication for risk stratification

Minerva Cardioangiologica

Volumn 55, Issue 3, 2007, Pages 325-333

  Piepoli, M F ^a   Capucci, A ^a  

^a GUGLIELMO DA SALICETO HOSPITAL   (Italy)

Author keywords

Arrythmias; Heart failure, congestive; Risk factors

Indexed keywords

ALDOSTERONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSIDE; METOPROLOL; PHENYLEPHRINE; PROPRANOLOL;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RISK; DEFIBRILLATOR; DRUG MECHANISM; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; NONHUMAN; PATHOGENESIS; PRESSORECEPTOR REFLEX; PROGNOSIS; REVIEW; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA; AUTONOMIC NERVOUS SYSTEM; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 34447504993     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
2. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
3. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334-51.
4. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (CAT). Circulation 2002;105:1453-8.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
6. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997;95:169-75.
7. Schmidt H, Francis DP, Rauchhaus M, Werdan K, Piepoli MF. Chemo- and ergoreflexes in health, disease and ageing. Int J Cardiol 2005;98:369-78.
8. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988;78:969-79.
9. European Society of Cardiology, NASPE. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of Cardiology and the North Ameriand Electrophysiology. Circulation 1996;93:1043-65.
10. Malik M. Geometrical methods for heart rate variability assessment. In: Malik M, Camm AJ editors. Heart rate variability. Armonk, NY: Futura Publishing; 1995. p. 47-61.
11. Piepoli M, Coats AJ. Autonomic abnormality in chronic heart failure evaluated by heart rate variability. Clin Sci (Lond) 1996;91 Suppl:84-6.
12. Lombardi F. Chaos theory, heart rate variability, and arrhythmic mortality. Circulation 2000;101:8-10.
13. Sleight P, La Rovere MT, Mortara A, Pinna G, Maestri R, Leuzzi S et al. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci (Lond) 1995;88:103-9.
14. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res 1969;24:109-21.
15. James MA, Panerai RB, Potter JF. Applicability of new techniques in the assessment of arterial baroreflex sensitivity in the elderly: a comparison with established pharmacological methods. Clin Sci (Lond) 1998;94:245-53.
16. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G et al. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 1988;12:600-10.
17. Pinna GD, Maestri R, Raczak G, La Rovere MT. Measuring baroreflex sensitivity from the gain function between arterial pressure and heart period. Clin Sci (Lond) 2002;103:81-8.
18. Imai K, Sato H, Hori M, Kusuoka H, Ozaki H, Yokoyama H et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol 1994;24:1529-35.
19. Mrowka R, Persson PB, Theres H, Patzak A. Blunted arterial baroreflex causes "pathological" heart rate turbulence. Am J Physiol Regul Integr Comp Physiol 2000;279:R1171-5.
20. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 1997;96:3450-8.
21. Kearney MT, Fox KA, Lee AJ, Prescott RJ, Shah AM, Batin PD et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002;40:1801-8.
22. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001;103:2072-7.
23. Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 1990;81:1959-66.
24. Krum H, Bigger JT Jr, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-94.
25. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997;336:525-33.
26. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8.
27. Parker GW, Michael LH, Hartley CJ, Skinner JE, Entman ML. Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res 1990;66:259-70.
28. Lin JL, Chan HL, Du CC, Lin IN, Lai CW, Lin KT et al. Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study. Am Heart J 1999;137:658-65.
29. Bonaduce D, Marciano F, Petretta M, Migaux ML, Morgano G, Bianchi V et al. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 1994;90:108-13.
30. Vaile JC, Chowdhary S, Osman F, Ross HF, Fletcher J, Littler WA et al. Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure. Clin Sci (Lond) 2001;101:559-66.
31. Wang W, McClain JM, Zucker IH. Aldosterone reduces baroreceptor discharge in the dog. Hypertension 1992;19:270-7.
32. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-70.
33. Coletta A, Thackray S, Nikitin N, Cleland JG. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail 2002;4:381-8.
34. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (the european myocardial infarct amiodarone trial). J Am Coll Cardiol 2000;35:1263-75.
35. Klingenheben T, Zabel M, D'Agostino RB, Cohen RJ, Hohnloser SH. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 2000;356:651-2.